FDA clears Nuvo's IND for Lidocaine Spray formulation
Links shared publicly online about this topic.
- 184total visits
FDA clears Nuvo's IND for Lidocaine Spray formulation
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application filed May 27, 2011 for a novel topical Lidocaine Spray formulation (NRI-ANA), allowing for initiation of Phase 1 studies.
View full resource at news-medical.net
Tags: Pain, Diet and Nutrition, Drug, Pharma, Phase 1 Clinical Trial, FDA, Lidoderm
Most Recently Shared on June 29, 2011 at 5:27 am By:
FDA clears Nuvo's IND for Lidocaine Spray formulation: Nuvo Research Inc., a specialty pharmaceutical company de... http://bit.ly/k39ngP
Advertisement
